The Journal of Organic Chemistry
ARTICLE
(m, 1H, 20-Hβ), 3.05 (s, 3H, NCH3), 3.18 (s, 3H, NCH3), 3.42ꢀ3.50
(m, 2H, 50-H2), 3.76ꢀ3.81 (m, 1H, 40-H), 4.38ꢀ4.40 (m, 2H, 30-H,
CtCH), 4.76 (t, J = 5.7 Hz, 1H, 50-OH), 5.30ꢀ5.31 (d, J = 4.2 Hz, 1H,
30-OH), 6.45 (t, J = 6.3 Hz, 1H, 10-H), 8.67 (s, 1H, NdCH), 11.36 (s,
1H, HN). Anal. Calcd for C15H18N6O4 (346.14): C, 52.02; H, 5.24; N,
24.27. Found: C, 52.54; H, 5.16; N, 24.46.
6.78 (br s, 2H, NH2), 7.32ꢀ7.41 (m, 4H, H-phenylene), 8.95 (s, 1H,
H-triazole), 10.75 (s, 1H, HN); ESI-TOF calcd for C20H21N11O4Na (M
þ Naþ) 502.1670, m/z found 502.1671. Anal. Calcd for C20H21N11O4
(479.45): C, 50.10; H, 4.41; N, 32.14. Found: C, 50.10; H, 4.51; N, 31.95.
6-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,5-di-
hydro-3-[[1-(4-azidomethylbenzyl)-1H-(1,2,3-trizol-4-yl)]hexyl-
idene]-4H-pyrazolo[3,4-d]pyrimidin-4-one (5). To a solution of
compound 2 (74.2 mg, 0.2 mmol) and 3 (188 mg, 1.0 mmol) in
THFꢀH2Oꢀt-BuOH, 3:1:1 (3 mL) was added a freshly prepared 1 M
solution of sodium ascorbate (159 μL, 0.16 mmol) in water, followed by the
addition of copper(II) sulfate pentahydrate 7.5% in water (128 μL, 0.038
mmol). The reaction mixture was stirred in the dark at room temperature for
12 h. After completion of the reaction (monitored by TLC), the solvent was
evaporated, and the residue was applied to FC (silica gel, column 8 ꢁ 3 cm,
eluted with CH2Cl2/MeOH, 95:5 f 90:10 f 80:20). The main zone
afforded 5 as a colorless solid (67 mg, 60%): TLC (CH2Cl2/MeOH, 90:10)
Rf 0.58; λmax (MeOH)/nm 243 (ε/dm3 molꢀ1 cmꢀ1 51200), 280 (sh)
(13100); 1H NMR (DMSO-d6, 300 MHz) (δ, ppm) 1.55ꢀ1.60 (m, 2H,
CH2), 1.73ꢀ1.77 (m, 2H, CH2), 2.12ꢀ2.15 (m, 1H, 20-HR), 2.45ꢀ2.50
(m, 3H, CH2, 20-Hβ), 2.64ꢀ2.68 (m, 4H, 2x CH2), 3.43ꢀ3.49 (m, 1H, 50-
H), 3.75ꢀ3.76 (m, 1H, 40-H), 4.35 (s, 1H, 30-H), 4.42(s, 2H, PhCH2), 4.73
(m, 1H, 50-OH), 5.23 (s, 1H, 30-OH), 5.55 (s, 2H, PhCH2), 6.27 (t, J = 6.3
Hz, 1H, 10-H), 6.73 (br s, 2H, NH2), 7.29ꢀ7.37 (m, 4H, H-phenylene),
7.94 (s, 1H, H-triazole), 10.68 (s, 1H, HN); ESI-TOF calcd for
C26H29N11O4Na (M þ Naþ) 582.2296, m/z found 582.2300. Anal.
Calcd for C26H29N11O4 (559.58): C, 55.81; H, 5.22; N, 27.53. Found: C,
56.17; H, 5.24.
6-[[(Dimethylamino)methylidene]amino]-1-[2-deoxy-5-O-
(4,40-dimethoxytriphenylmethyl)-β-D-erythro-pentofuranosyl]-
1,5-dihydro-3-ethynyl-4H-pyrazolo[3,4-d]pyrimidin-4-one
(11). Compound 10 (550 mg, 1.6 mmol) was dried by repeated
coevaporation with anhydrous pyridine and then dissolved in dry
pyridine (15 mL) and stirred with 4,40-dimethoxytrityl chloride (810
mg, 2.4 mmol) in the presence of N,N-diisopropylethylamine (430 μL,
2.4 mmol) at room temperature. After 6 h, the solution was poured into
5% aqueous NaHCO3 (100 mL) and extracted with CH2Cl2 (3 ꢁ
80 mL). The combined organic layers were dried (Na2SO4), the solvent
was evaporated, and the remaining oily residue was coevaporated with
toluene (3 ꢁ 10 mL) to afford a foamy residue which was applied to FC
(silica gel, column 10 ꢁ 4 cm, CH2Cl2/MeOH, 95:5 f 90:10).
Evaporation of the main zone afforded 11 as colorless foam (855 mg,
83%): TLC (CH2Cl2/MeOH, 90:10) Rf 0.53; λmax (MeOH)/nm 236
1
(ε/dm3 molꢀ1 cmꢀ1 33700), 246 (29400), 300 (25900); H NMR
(DMSO-d6, 300 MHz) (δ, ppm) 2.19ꢀ2.28 (m, 1H, 20-HR), 2.65ꢀ2.72
(m, 1H, 20-Hβ), 3.06 (s, 3H, NCH3), 3.19 (s, 3H, NCH3), 3.36 (m, 2H,
50-H2), 3.71 (s, 6H, 2 ꢁ OCH3), 3.87ꢀ3.89 (m, 1H, 40-H), 4.41 (s, 1H,
CtCH), 4.47ꢀ4.51 (m, 1H, 30-H), 5.32ꢀ5.34 (d, J = 4.8 Hz, 1H, 30-
OH), 6.48 (t, J = 4.2 Hz, 1H, 10-H), 6.77ꢀ6.82 (m, 4H, H-phenyl),
7.16ꢀ7.34 (m, 9H, H-phenyl), 8.71 (s, 1H, NdCH), 11.43 (s, 1H, HN).
Anal. Calcd for C36H36N6O6 (648.27): C, 66.65; H, 5.59; N, 12.96.
Found: C, 66.58; H, 5.66; N, 12.83.
Bis[6-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,5-di-
hydro-3-[[1-methylbenzyl-1H-(1,2,3-trizol-4-yl)]hexylidene]-4H-
pyrazolo[3,4-d]pyrimidin-4-one] (7). Evaporation of the minor zone
gave 7 as a white powder (14 mg, 15%). Analytical data are identical with
already published data.23
6-[[(Dimethylamino)methylidene]amino]-1-[2-deoxy-5-O-
(4,40-dimethoxytriphenylmethyl)-β-D-erythro-pentofuranosyl]-
1,5-dihydro-3-ethynyl-4H-pyrazolo[3,4-d]pyrimidin-4-one
30-[(2-Cyanoethyl)-N,N-(diisopropyl)]phosphoramidite (12).
A solution of 11 (560 mg, 0.86 mmol) in anhydrous CH2Cl2 (10 mL)
was treated with anhydrous (iPr)2NEt (300 μL, 1.34 mmol) at rt. Then
2-cyanoethyl diisopropylphosphoramidochloridite (320 μL, 1.77 mmol)
was added. After 3 h, the solution was washed with saturated NaHCO3
and extracted with CH2Cl2 (2 ꢁ 100 mL). The combined organic layer
was dried (Na2SO4), and the solvent was evaporated. FC (silica gel,
column 8 ꢁ 3 cm, CH2Cl2/MeOH, 95:5) afforded 12 as a colorless foam
(540 mg, 74%): TLC (CH2Cl2/MeOH, 95: 5) Rf 0.74; 31P NMR
(CDCl3, 121.5 MHz) (δ, ppm) 148.36. Anal. Calcd for C45H53N8O7P
(848.38): C, 63.67; H, 6.29; N, 13.20. Found: C, 63.89; H, 6.36; N, 13.20.
Monofunctionalization of 1,4-Bis-azidomethylbenzene
(3) with Nucleosides 1 and 2. 6-Amino-1-(2-deoxy-β-D-ery-
thro-pentofuranosyl)-1,5-dihydro-3-[1-(4-azidomethylbe-
nzyl)-1H-[1,2,3-trizol-4-yl]]-4H-pyrazolo[3,4-d]pyrimidin-4-
one (4). To a solution of compound 1 (58.3 mg, 0.2 mmol) and 3 (188
mg, 1.0 mmol) in THFꢀH2Oꢀt-BuOH, 3:1:1 (3 mL) was added a
freshly prepared 1 M solution of sodium ascorbate (159 μL, 0.16 mmol)
in water, followed by the addition of copper(II) sulfate pentahydrate
7.5% in water (128 μL, 0.038 mmol). The reaction mixture was stirred in
the dark at room temperature for 12 h. After completion of the reaction
(monitored by TLC), the solvent was evaporated, and the residue was
applied to FC (silica gel, column 8 ꢁ 3 cm, eluted with CH2Cl2/MeOH,
95:5 f 90:10). Evaporation of the main zone gave 4 as a pale yellow
solid (71 mg, 74%): TLC (CH2Cl2/MeOH, 80:20) Rf 0.60; λmax
(MeOH)/nm 246 (ε/dm3 molꢀ1 cmꢀ1 48600), 260 (26000), 280
(12000). 1H NMR (DMSO-d6, 300 MHz) (δ, ppm) 2.15ꢀ2.23 (m, 1H,
20-HR), 2.74ꢀ2.83 (m, 1H, 20-Hβ), 3.40ꢀ3.44 (m, 1H, 50-H),
3.51ꢀ3.56 (m, 1H, 50-H), 3.77ꢀ3.80 (m, 1H, 40-H), 4.44ꢀ4.49 (m,
3H, 30-H, PhCH2), 4.79 (t, J = 5.7 Hz, 1H, 50-OH), 5.26ꢀ5.27 (d, J = 4.2
Hz, 1H, 30ꢀOH), 5.75 (s, 2H, PhCH2), 6.36 (t, J = 6.3 Hz, 1H, 10-H),
“Bis-click” Cross-LinkingofNucleoside 1 with1,4-Bis-azido-
methylbenzene (3). Bis[6-Amino-1-(2-deoxy-β-D-erythro-
pentofuranosyl)-1,5-dihydro-3-[1-methylbenzyl-1H-(1,2,3-
trizol-4-yl)]-4H-pyrazolo[3,4-d]pyrimidin-4-one] (6). To a so-
lution of compound 1 (116.6 mg, 0.4 mmol) and 3 (37.6 mg, 0.2 mmol)
in THFꢀH2Oꢀt-BuOH, 3: 1: 1 (6 mL) was added a freshly prepared 1
M solution of sodium ascorbate (318 μL, 0.32 mmol) in water, followed
by the addition of copper(II) sulfate pentahydrate 7.5% in water (256
μL, 0.076 mmol), and the reaction mixture was stirred at room
temperature for 12 h. After completion of the reaction (monitored by
TLC), the mixture was filtered and the solid residue was washed with
methanol (5 mL) and water (5 mL). Compound 6 was obtained as a
yellow solid (80 mg, 52%): λmax (0.1 M NaOH)/nm 242 (ε/dm3
1
molꢀ1 cmꢀ1 47 500), 260 (sh) (31800); H NMR (DMSO-d6, 300
MHz) (δ, ppm) 2.11ꢀ2.18 (m, 2H, 20-HR), 2.76ꢀ2.80 (m, 2H, 20-Hβ),
3.51ꢀ3.55 (m, 4H, 50-H2), 3.78ꢀ3.79 (m, 2H, 40-H), 4.43ꢀ4.47 (m,
2H, 30-H), 4.78 (t, J = 5.1 Hz, 2H, 50-OH), 5.25ꢀ5.26 (d, J = 3.3 Hz, 2H,
30-OH), 5.72 (s, 4H, 2 ꢁ PhCH2), 6.35 (t, J = 6.0 Hz, 2H, 10-H), 6.76 (br
s, 4H, 2 ꢁ H2N), 7.33ꢀ7.40 (m, 4H, H-phenylene), 8.94 (s, 2H, 2 ꢁ
H-triazole), 10.74 (s, 2H, 2 ꢁ HN). Anal. Calcd for C32H34N16O8
(770.71): C, 49.87; H, 4.45; N, 29.08. Found: C, 49.49; H, 4.22; N, 28.65.
6-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,5-di-
hydro-3-[1-(4-azidomethylbenzyl)-1H-[1,2,3-trizol-4-yl]]-4H-
pyrazolo[3,4-d]pyrimidin-4-one (4). The remaining solution was
evaporatedtodryness, andtheresiduewasappliedtoFC(silicagel, column
8 ꢁ 3 cm, eluted with CH2Cl2/MeOH, 95:5 f 90:10). Compound 4 was
isolated as a white powder (14 mg, 7%). For analytical data of 4, see above.
General Procedure for the “Stepwise Click” Huisgenꢀ
SharplessꢀMeldal [3 þ 2] Cycloaddition. Azidomethylben-
zyl-Labeled Oligonucleotides (ODN-22ꢀODN-27) Using
Oligonucleotides ODN-16ꢀODN-21 and the Bis-Azide 3
(“1.Click”). To the single-stranded oligonucleotide (5 A260 units) were
5595
dx.doi.org/10.1021/jo2004988 |J. Org. Chem. 2011, 76, 5584–5597